Geoffrey D. Coxon

790 total citations
17 papers, 649 citations indexed

About

Geoffrey D. Coxon is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Geoffrey D. Coxon has authored 17 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Infectious Diseases and 6 papers in Organic Chemistry. Recurrent topics in Geoffrey D. Coxon's work include Tuberculosis Research and Epidemiology (9 papers), Cancer therapeutics and mechanisms (6 papers) and Biochemical and Molecular Research (6 papers). Geoffrey D. Coxon is often cited by papers focused on Tuberculosis Research and Epidemiology (9 papers), Cancer therapeutics and mechanisms (6 papers) and Biochemical and Molecular Research (6 papers). Geoffrey D. Coxon collaborates with scholars based in United Kingdom, United States and France. Geoffrey D. Coxon's co-authors include Lynn G. Dover, Laurent Kremer, Gurdyal S. Besra, Robert C. Reynolds, David E. Minnikin, Simon P. Mackay, James C. Sacchettini, Yann Guérardel, Anuradha Alahari and Xavier Trivelli and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

In The Last Decade

Geoffrey D. Coxon

17 papers receiving 634 citations

Peers

Geoffrey D. Coxon
Brenda R. McDougall United States
Laura Friggeri United States
Mahmut Ülger Türkiye
Chong-Kyo Lee South Korea
Jiyoun Nam South Korea
Geoffrey D. Coxon
Citations per year, relative to Geoffrey D. Coxon Geoffrey D. Coxon (= 1×) peers Davie Cappoen

Countries citing papers authored by Geoffrey D. Coxon

Since Specialization
Citations

This map shows the geographic impact of Geoffrey D. Coxon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey D. Coxon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey D. Coxon more than expected).

Fields of papers citing papers by Geoffrey D. Coxon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey D. Coxon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey D. Coxon. The network helps show where Geoffrey D. Coxon may publish in the future.

Co-authorship network of co-authors of Geoffrey D. Coxon

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey D. Coxon. A scholar is included among the top collaborators of Geoffrey D. Coxon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey D. Coxon. Geoffrey D. Coxon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Halloum, Iman, Albertus Viljoen, Christiane Bouchier, et al.. (2017). Resistance to Thiacetazone Derivatives Active against Mycobacterium abscessus Involves Mutations in the MmpL5 Transcriptional Repressor MAB_4384. Antimicrobial Agents and Chemotherapy. 61(4). 59 indexed citations
2.
Zhang, Tong, et al.. (2014). Characterisation of triterpenes and new phenolic lipids in Cameroonian propolis. Phytochemistry. 106. 156–163. 57 indexed citations
3.
Coxon, Geoffrey D., et al.. (2013). Synthesis, Antitubercular Activity and Mechanism of Resistance of Highly Effective Thiacetazone Analogues. PLoS ONE. 8(1). e53162–e53162. 60 indexed citations
4.
Coxon, Geoffrey D., Christopher B. Cooper, Stephen H. Gillespie, & Timothy D. McHugh. (2012). Strategies and Challenges Involved in the Discovery of New Chemical Entities During Early-Stage Tuberculosis Drug Discovery. The Journal of Infectious Diseases. 205(suppl_2). S258–S264. 12 indexed citations
5.
Dover, Lynn G. & Geoffrey D. Coxon. (2011). Current Status and Research Strategies in Tuberculosis Drug Development. Journal of Medicinal Chemistry. 54(18). 6157–6165. 100 indexed citations
6.
Coxon, Geoffrey D., et al.. (2011). Synthesis of cis,cis-diunsaturated α-meromycolic acid by a palladium-catalysed alkyl–alkyl Negishi reaction. Tetrahedron Letters. 53(2). 214–216. 4 indexed citations
7.
Dover, Lynn G. & Geoffrey D. Coxon. (2011). Correction to Current Status and Research Strategies in Tuberculosis Drug Development. Journal of Medicinal Chemistry. 54(23). 8233–8233. 3 indexed citations
8.
Al‐Balas, Qosay, Nahoum G. Anthony, Amani Alnimr, et al.. (2009). Identification of 2-Aminothiazole-4-Carboxylate Derivatives Active against Mycobacterium tuberculosis H37Rv and the β-Ketoacyl-ACP Synthase mtFabH. PLoS ONE. 4(5). e5617–e5617. 47 indexed citations
9.
Coxon, Geoffrey D., Brian L. Furman, Alan L. Harvey, et al.. (2009). Benzylguanidines and Other Galegine Analogues Inducing Weight Loss in Mice. Journal of Medicinal Chemistry. 52(11). 3457–3463. 16 indexed citations
10.
Mooney, Mark, Sarah Fogarty, Alison Gallagher, et al.. (2008). Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice. British Journal of Pharmacology. 153(8). 1669–1677. 57 indexed citations
11.
Alahari, Anuradha, Xavier Trivelli, Yann Guérardel, et al.. (2007). Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria. PLoS ONE. 2(12). e1343–e1343. 101 indexed citations
12.
Carter, Katharine C., Alexander B. Mullen, Geoffrey D. Coxon, et al.. (2006). Identification of the benzodiazepines as a new class of antileishmanial agent. Bioorganic & Medicinal Chemistry Letters. 17(3). 624–627. 40 indexed citations
13.
Bhowruth, Veemal, Alistair K. Brown, Robert C. Reynolds, et al.. (2006). Symmetrical and unsymmetrical analogues of isoxyl; active agents against Mycobacterium tuberculosis. Bioorganic & Medicinal Chemistry Letters. 16(18). 4743–4747. 36 indexed citations
14.
Coxon, Geoffrey D., Juma’a R. Al Dulayymi, Caroline Morehouse, et al.. (2003). Synthesis and properties of methyl 5-(1′R,2′S)-(2-octadecylcycloprop-1-yl)pentanoate and other ω-19 chiral cyclopropane fatty acids and esters related to mycobacterial mycolic acids. Chemistry and Physics of Lipids. 127(1). 35–46. 10 indexed citations
15.
Coxon, Geoffrey D., James Douglas, & David E. Minnikin. (2003). Facile synthesis of (Z)-tetracos-5-enoic acid and racemic cis-4-(2-octadecylcyclopropane-1-yl)-butanoic acid. Chemistry and Physics of Lipids. 126(1). 49–53. 5 indexed citations
16.
Coxon, Geoffrey D., et al.. (2003). The synthesis of (11R,12S)-lactobacillic acid and its enantiomer. Tetrahedron Asymmetry. 14(9). 1211–1222. 26 indexed citations
17.
Coxon, Geoffrey D., et al.. (1999). The synthesis of both enantiomers of lactobacillic acid and mycolic acid analogues. Tetrahedron Letters. 40(36). 6689–6692. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026